Profluent Bio
PrivateLast Round
Series B
Nov 19, 2025
Est. Valuation
$975M
Total Funding Raised
$362M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Profluent Bio is a biotechnology company that develops artificial intelligence-based models to design and validate novel, functional proteins for human health and industrial applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Profluent Bio Comparables
Compare Profluent Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evozyne | 88% | |
| Generate Biomedicines | 86% | |
| EvolutionaryScale | 85% | |
Profluent Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 19, 2025 | ||||
| Early Funding | Nov 19, 2025 | ||||
| Series B | May 22, 2024 | ||||
| Series A | Mar 21, 2024 | ||||
| Seed | Jan 26, 2023 |
Profluent Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Air Street Capital | Series B, Early Funding, Seed, Series A |
| Bezos Expeditions | Series B, Early Funding |
| Convergent Ventures | Seed |
| Spark Capital | Series B, Early Funding, Series A |
| AIX Ventures | Seed |
| Insight Partners | Series B, Early Funding, Series A, Seed |
| Altimeter Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Grew 23% QoQ from 56 to 69 employees.
- Apr 28, 2026
Multi-program deal worth up to $2.25 billion for AI-designed enzymes.
Profluent Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Profluent Bio's valuation, stock price, and market status.